PRIVATE & CONFIDENTIALPrivate & Confidential • July 11th, 2016 • Endonovo Therapeutics, Inc. • Pharmaceutical preparations • California
This binding letter agreement (“LOI”), which has been approved by the Boards of Directors of each of the parties hereto and is subject only to completion of Definitive Documents and required Shareholder approvals outlines the intentions of Endonovo Therapeutics, Inc. (“Buyer”) with respect to the purchase (“Transaction”) of all of the outstanding Common and Preferred Shares (the “Stock”) of the Company on terms as follows:
